Skip to main content
All lobbying filings

COUNCIL FOR INNOVATION PROMOTION (C4IP)

Lobbying for COUNCIL FOR INNOVATION PROMOTION (C4IP) · A coalition dedicated to promoting strong IP rights that drive innovation.

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$90,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 16
  • S 2220
    Fighting for the Overlooked Recognition of Groups Operating in Toxic Test Environments in Nevada (FORGOTTEN) Veterans A…
  • HR 4370
    SAMS Act of 2025
  • S 2140
    Patent Eligibility Restoration Act of 2023
  • HR 9474
    Patent Eligibility Restoration Act of 2024
  • S 4840
    RESTORE Patent Rights Act of 2024
  • HR 9221
    RESTORE Patent Rights Act of 2024
  • S 2780
    Medication Affordability and Patent Integrity Act
  • S 527
    Prescription Pricing for the People Act of 2025
  • S 1040
    A bill to amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Healt…
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
  • S 1367
    NO FAKES Act of 2025
  • HR 2794
    NO FAKES Act of 2025
  • S 1095
    Stop STALLING Act
  • S 2276
    ETHIC Act
  • HR 3269
    ETHIC Act
 Lobbying activity 2
Copyright/Patent/Trademark

General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140, H.R. 9474 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025 S.1367, H.R. 2794, No Fakes Act S. 1095. The Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act S. 2276/H.R. 3269 Eliminating Thickets to Increase Competition Act (Ethics Act)

Trade (domestic/foreign)

General advocacy in support of pro-IP/innovation policies ITC - IP-related issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem